Edition:
India

Dr.Reddy's Laboratories Ltd (REDY.NS)

REDY.NS on National Stock Exchange of India

2,322.60INR
17 Nov 2017
Change (% chg)

Rs-10.95 (-0.47%)
Prev Close
Rs2,333.55
Open
Rs2,333.55
Day's High
Rs2,356.95
Day's Low
Rs2,303.00
Volume
274,657
Avg. Vol
790,648
52-wk High
Rs3,258.00
52-wk Low
Rs1,901.15

Latest Key Developments (Source: Significant Developments)

Dr.Reddy's Labs ‍launches clofarabine injection in U.S.
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Dr.Reddy's Laboratories Ltd ::Says ‍launch of clofarabine injection in U.S. market​.  Full Article

DR. REDDY'S LABORATORIES LAUNCHES GENERIC AZACITIDINE FOR INJECTION IN CANADIAN MARKET
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Dr.Reddy's Laboratories Ltd :DR REDDY'S LABORATORIES ANNOUNCES THE LAUNCH OF GENERIC AZACITIDINE FOR INJECTION IN THE CANADIAN MARKET.GENERIC AZACITIDINE FOR INJECTION 100 MG/VIAL, A BIOEQUIVALENT GENERIC VERSION OF VIDAZA IS APPROVED BY HEALTH CANADA​.  Full Article

India's Dr.Reddy's Laboratories Sept-qtr consol PAT down about 1 pct
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Dr.Reddy's Laboratories Ltd ::Sept quarter consol net profit after tax 3.05 billion rupees versus 3.09 billion rupees last year.Consensus forecast for sept quarter consol profit was 2.88 billion rupees.Sept quarter consol net sales 34.91 billion rupees versus 35.29 billion rupees last year.Expect to see results from products launched in U.S. during first half of the fiscal‍​.  Full Article

Dr Reddy's says U.S. court finds co's product infringes some patents
Thursday, 16 Feb 2017 

Dr.Reddy's Laboratories Ltd : Says Dr. Reddy's Laboratories announces U.S. district court's opinion relating to patent infringement . Court found that asserted claims of the "094" and "980" patents were not invalid .Court found that co's proposed palonosetron hydrochloride product infringes certain claims of some U.S. patents.  Full Article

Dr.Reddy's Labs exec says co has addressed all FDA requirements on warning letters
Tuesday, 25 Oct 2016 

Dr.Reddy's Laboratories Ltd : Exec says have addressed all FDA requirements on warning letters . Exec says pricing erosion has become a part of U.S. business model Further company coverage: [REDY.NS] (Bengaluru newsroom) ((ReutersIndia.snapping@thomsonreuters.com ;)).  Full Article

Dr.Reddy's Labs announces entry into Columbia
Friday, 7 Oct 2016 

Dr.Reddy's Laboratories Ltd :Announces entry into Columbia.  Full Article

DR. Reddy's laboratories says launch of Bupropion HCL extended-release tablets, USP (sr) in U.S. market
Friday, 2 Sep 2016 

Dr.Reddy's Laboratories Ltd :Launch of bupropion hcl extended-release tablets, usp (sr) in u.s. Market.  Full Article

Dr.Reddy's Laboratories says June-qtr consol net profit falls about 76.2 pct
Tuesday, 26 Jul 2016 

Dr.Reddy's Laboratories Ltd : June -quarter pat 4.09 billion rupees - tv . June -quarter consol net profit 1.54 billion rupees; consol net sales inr 31.64 billion . Consensus forecast for June-quarter profit was 4.95 billion rupees . Consol net profit in June-quarter last year was 6.47 billion rupees as per Ind-AS; consol net sales was 37.01 billion rupees . In quarter, top and bottom lines impacted by fall in volume growth, mainly in U.S. markets, loss of business in Venezuela . Co faced challenges in quarter including price erosion and delayed launches due to warning letter, which significantly impacted earnings .  Full Article

Spectrum Pharma says Dr Reddy's will be permitted to market generic version of Folotyn in US on Dec 1, 2022 or earlier
Tuesday, 31 May 2016 

Spectrum Pharmaceuticals : Co's unit, dr. Reddy's labs, ltd entered into settlement agreement to resolve their patent litigation relating to folotyn .dr. Reddy's will be permitted to market generic version of folotyn in u.s. On december 1, 2022 or earlier under certain circumstances.  Full Article

Dr. Reddy's Labs acquires six OTC brands from Ducere Pharma
Wednesday, 25 May 2016 

Dr.Reddy's Laboratories Ltd : Dr. Reddy's enters the branded consumer health arena through the acquisition of six OTC brands . Co acquired six OTC brands from Ducere Pharma .  Full Article

Photo

Factbox: How corporate numbers on Indian WhatsApp groups compared with actual results

Reuters has documented at least 12 cases of prescient messages about major Indian companies being posted in private WhatsApp groups.